Delivery Order SPE2DB20D3103-SPE2DB24FN7U7

Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mucinex D ER 600-60 mg tablets. The firm-fixed-price delivery order, valued at $1,887.60, has an ultimate completion date of September 30, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, through its Corporate Office division, will supply the requested medication to support DLA's military...
This federal contract award, valued at $1,078.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mucinex D ER 600-60 mg tablets, a pharmaceutical product, and has a completion date of March 13, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Mucinex D ER 600-60 MG tablets, a pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $6,917.20 and an ultimate completion date of January 17, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.69 firm fixed-price delivery order is for the supply of Mucinex D ER 600-60 mg tablets, which will be delivered by February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, that serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,226.61 and covers the supply of Mucinex D ER 600-60 mg tablets. The contract is not set aside and is a firm fixed-price arrangement. It has an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,043.80 fixed-price delivery order is for the supply of Mucinex DM ER 600-30 mg tablets. The contract has a period of performance through July 16, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,688.25 firm-fixed-price delivery order is for Mucinex D ER 600-60 mg tablets, with a completion date of September 5, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this award, which is not a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,197.09, is for the delivery of MUCINEX D ER 600-60 MG TABLET 18S and has an ultimate completion date of March 18, 2025. The contract is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MUCINEX D ER 600-60 MG TABLET 18S. The contract has a ceiling value of $7,276.85 and an ultimate completion date of August 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these prescription drugs to support military treatment facilities and other federal healthcare programs. This award is part of a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,125.58, is a delivery order for the supply of MUCINEX D ER 600-60 MG TABLET 18S. The contract has an ultimate completion date of June 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FN7U7
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mucinex D ER 600-60 MG Tablets, with a ceiling value of $3,540.83 and a completion date of May 13, 2024. This is a Firm Fixed Price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 11:48 AM